Cargando…

Severe type 2 diabetes (T2D) remission using a very low-calorie ketogenic diet (VLCKD)

SUMMARY: There is a close association between obesity and type 2 diabetes (T2D). The value of weight loss in the management of patients with T2D has long been known. Loss of 15% or more of body weight can have a disease-modifying effect in people with diabetes inducing remission in a large proportio...

Descripción completa

Detalles Bibliográficos
Autores principales: Correa, Livia Lugarinho, Medeiros de Sousa, Priscila Alves, Dinis, Leticia, Carloto, Luana Barboza, Nuñez-Garcia, Maitane, Sajoux, Ignacio, Senhorini, Sidney
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513631/
https://www.ncbi.nlm.nih.gov/pubmed/36094136
http://dx.doi.org/10.1530/EDM-22-0295
_version_ 1784798111113150464
author Correa, Livia Lugarinho
Medeiros de Sousa, Priscila Alves
Dinis, Leticia
Carloto, Luana Barboza
Nuñez-Garcia, Maitane
Sajoux, Ignacio
Senhorini, Sidney
author_facet Correa, Livia Lugarinho
Medeiros de Sousa, Priscila Alves
Dinis, Leticia
Carloto, Luana Barboza
Nuñez-Garcia, Maitane
Sajoux, Ignacio
Senhorini, Sidney
author_sort Correa, Livia Lugarinho
collection PubMed
description SUMMARY: There is a close association between obesity and type 2 diabetes (T2D). The value of weight loss in the management of patients with T2D has long been known. Loss of 15% or more of body weight can have a disease-modifying effect in people with diabetes inducing remission in a large proportion of patients. Very low-carbohydrate ketogenic diets (VLCKDs) have been proposed as an appealing nutritional strategy for obesity management. The diet was shown to result in significant weight loss in the short, intermediate, and long terms and improvement in body composition parameters as well as glycemic and lipid profiles. The reported case is a 35-year-old man with obesity, dyslipidemia, and T2D for 5 years. Despite the use of five antidiabetic medications, including insulin, HbA1c was 10.1%. A VLCKD through a commercial multidisciplinary weight loss program (PnK method) was prescribed and all medications were discontinued. The method is based on high-biological-value protein preparations and has 5 steps, the first 3 steps (active stage) consist of a VLCKD (600–800 kcal/d) that is low in carbohydrates (<50 g daily from vegetables) and lipids. The amount of proteins ranged between 0.8 and 1.2 g/kg of ideal body weight. After only 3 months, the patient lost 20 kg with weight normalization and diabetes remission, and after 2 years of follow-up, the patient remained without the pathologies. Due to the rapid and significant weight loss, VLCKD emerges as a useful tool in T2D remission in patients with obesity. LEARNING POINTS: Obesity and type 2 diabetes (T2D) are conditions that share key pathophysiological mechanisms. Loss of 15% or more of body weight can have a disease-modifying effect in people with T2D inducing remission in a large proportion of patients. Diabetes remission should be defined as a return of HbA1c to <6.5% and which persists for at least 3 months in the absence of usual glucose-lowering pharmacotherapy. The very low-carbohydrate ketogenic diet (VLCKD) is a nutritional approach that has significant beneficial effects on anthropometric and metabolic parameters. Due to the rapid and significant weight loss, VLCKD emerges as a useful tool in T2D remission in patients with obesity.
format Online
Article
Text
id pubmed-9513631
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Bioscientifica Ltd
record_format MEDLINE/PubMed
spelling pubmed-95136312022-09-28 Severe type 2 diabetes (T2D) remission using a very low-calorie ketogenic diet (VLCKD) Correa, Livia Lugarinho Medeiros de Sousa, Priscila Alves Dinis, Leticia Carloto, Luana Barboza Nuñez-Garcia, Maitane Sajoux, Ignacio Senhorini, Sidney Endocrinol Diabetes Metab Case Rep Insight into Disease Pathogenesis or Mechanism of Therapy SUMMARY: There is a close association between obesity and type 2 diabetes (T2D). The value of weight loss in the management of patients with T2D has long been known. Loss of 15% or more of body weight can have a disease-modifying effect in people with diabetes inducing remission in a large proportion of patients. Very low-carbohydrate ketogenic diets (VLCKDs) have been proposed as an appealing nutritional strategy for obesity management. The diet was shown to result in significant weight loss in the short, intermediate, and long terms and improvement in body composition parameters as well as glycemic and lipid profiles. The reported case is a 35-year-old man with obesity, dyslipidemia, and T2D for 5 years. Despite the use of five antidiabetic medications, including insulin, HbA1c was 10.1%. A VLCKD through a commercial multidisciplinary weight loss program (PnK method) was prescribed and all medications were discontinued. The method is based on high-biological-value protein preparations and has 5 steps, the first 3 steps (active stage) consist of a VLCKD (600–800 kcal/d) that is low in carbohydrates (<50 g daily from vegetables) and lipids. The amount of proteins ranged between 0.8 and 1.2 g/kg of ideal body weight. After only 3 months, the patient lost 20 kg with weight normalization and diabetes remission, and after 2 years of follow-up, the patient remained without the pathologies. Due to the rapid and significant weight loss, VLCKD emerges as a useful tool in T2D remission in patients with obesity. LEARNING POINTS: Obesity and type 2 diabetes (T2D) are conditions that share key pathophysiological mechanisms. Loss of 15% or more of body weight can have a disease-modifying effect in people with T2D inducing remission in a large proportion of patients. Diabetes remission should be defined as a return of HbA1c to <6.5% and which persists for at least 3 months in the absence of usual glucose-lowering pharmacotherapy. The very low-carbohydrate ketogenic diet (VLCKD) is a nutritional approach that has significant beneficial effects on anthropometric and metabolic parameters. Due to the rapid and significant weight loss, VLCKD emerges as a useful tool in T2D remission in patients with obesity. Bioscientifica Ltd 2022-08-22 /pmc/articles/PMC9513631/ /pubmed/36094136 http://dx.doi.org/10.1530/EDM-22-0295 Text en © The authors https://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Insight into Disease Pathogenesis or Mechanism of Therapy
Correa, Livia Lugarinho
Medeiros de Sousa, Priscila Alves
Dinis, Leticia
Carloto, Luana Barboza
Nuñez-Garcia, Maitane
Sajoux, Ignacio
Senhorini, Sidney
Severe type 2 diabetes (T2D) remission using a very low-calorie ketogenic diet (VLCKD)
title Severe type 2 diabetes (T2D) remission using a very low-calorie ketogenic diet (VLCKD)
title_full Severe type 2 diabetes (T2D) remission using a very low-calorie ketogenic diet (VLCKD)
title_fullStr Severe type 2 diabetes (T2D) remission using a very low-calorie ketogenic diet (VLCKD)
title_full_unstemmed Severe type 2 diabetes (T2D) remission using a very low-calorie ketogenic diet (VLCKD)
title_short Severe type 2 diabetes (T2D) remission using a very low-calorie ketogenic diet (VLCKD)
title_sort severe type 2 diabetes (t2d) remission using a very low-calorie ketogenic diet (vlckd)
topic Insight into Disease Pathogenesis or Mechanism of Therapy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513631/
https://www.ncbi.nlm.nih.gov/pubmed/36094136
http://dx.doi.org/10.1530/EDM-22-0295
work_keys_str_mv AT correalivialugarinho severetype2diabetest2dremissionusingaverylowcalorieketogenicdietvlckd
AT medeirosdesousapriscilaalves severetype2diabetest2dremissionusingaverylowcalorieketogenicdietvlckd
AT dinisleticia severetype2diabetest2dremissionusingaverylowcalorieketogenicdietvlckd
AT carlotoluanabarboza severetype2diabetest2dremissionusingaverylowcalorieketogenicdietvlckd
AT nunezgarciamaitane severetype2diabetest2dremissionusingaverylowcalorieketogenicdietvlckd
AT sajouxignacio severetype2diabetest2dremissionusingaverylowcalorieketogenicdietvlckd
AT senhorinisidney severetype2diabetest2dremissionusingaverylowcalorieketogenicdietvlckd